Efficacy
of Hypoxytherapy in the treatment of different diseases
in patients in the prophylaxic clinic "Tamara",
Murmansk, Russia.
[Kononenko et al, 1997]
| Clinical
Results of IHT Treatment of Various Diseases |
| N |
Pathology |
All
cases |
From
10 to 15 IHT sessions |
From
16 to 25 IHT sessions |
| |
|
|
In
all |
Inprove-
ments |
Without
changes |
In
all |
Inprove-
ments |
Without
changes |
| 1 |
Ischaemic
Heart Disease (IHD) |
88 |
55 |
52 |
3 |
33 |
32 |
1 |
| 2 |
IHD
+ Hypertension |
6 |
4 |
3 |
1 |
2 |
2 |
- |
| 3 |
Hypertension |
116 |
77 |
72 |
5 |
39 |
31 |
2 |
| 4 |
Neurocirculatory
asthenia |
46 |
37 |
35 |
2 |
9 |
9 |
- |
| 5 |
Bronchial
asthma |
10 |
4 |
4 |
- |
6 |
6 |
- |
| 6 |
Chronic
bronchitis |
59 |
43 |
41 |
2 |
16 |
16 |
- |
| 7 |
Ulcerative
disease of stomach,
duodenum |
42 |
28 |
27 |
1 |
14 |
14 |
- |
| 8 |
Liver
and Pancreatic diseases |
31 |
25 |
23 |
2 |
6 |
6 |
- |
| 9 |
Diabetes
mellitus |
3 |
3 |
3 |
- |
- |
- |
- |
| 10 |
Toxaemia
of pregnancy |
2 |
- |
- |
- |
2 |
2 |
- |
| 11 |
Anaemia |
1 |
1 |
1 |
- |
- |
- |
- |
| 12 |
Diseases
of locomotion |
217 |
161 |
150 |
11 |
56 |
55 |
1 |
| 13 |
Diseases
of urinary tract |
20 |
13 |
13 |
- |
7 |
7 |
- |
| 14 |
Others |
46 |
34 |
32 |
2 |
12 |
11 |
1 |
| |
In
all |
687 |
485 |
456 |
29 |
202 |
197 |
5 |
| |
% |
|
100 |
94 |
|
100 |
97.5 |
2.5 |
TABLE 1.
Clinical Applications
of IHT
Statistically significant
data indicates that after a course of IHT treatment,
the following effects become apparent:
• Decrease in fatigue
• Decrease in head, joint, and chest pains
• Increase in working capacity
The number of complaints
in % to the number of all patients
Sanatorium "Orbita",
Kursk nuclear power
station (4180 cases)
[Agadzhanian et al, 1997].
Before IHT
After IHT
| Headache |
85
8 |
| Fatigue |
80
15 |
| Decrease
in working capacity |
77
5 |
| Unpleasant
sensations |
56
6 |
| Irritation |
89
18 |
| Insomnia |
64
9 |
| Breathlessness |
25
8 |
| Suffocation
fits |
4
1 |
| Arrhythmia |
58
20 |
| Chest
pain |
57
19 |
| Skin
eruption |
8
5 |
| Jointache |
34
16 |
| Cough |
12
3 |
| |
| 0 |
10 |
20 |
30 |
40 |
50 |
60 |
70 |
80 |
90% |
|
TABLE 2.
The results of IHT treatment ('Mountain
Air" treatment) in the prophylaxic clinic "Sanatorium
Tamara" Murmansk, Russia. (Kononenko et al, 1997)
| The
Number Of Complaints In % To Overall Number Of
Patients |
| N |
Complaints |
Before
IHT treatment |
After
IHT treatment |
p |
| 1 |
Headache |
39.2
± 1.5 |
7.1
± 0.8 |
<0.001 |
| 2 |
Chest
pains |
36.3
± 1.5 |
4.4
± 0.6 |
<0.001 |
| 3 |
Breathlessness |
24.7
± 1.3 |
13.7
± 1.0 |
<0.001 |
| 4 |
Suffocation
fits |
4.1
± 0.6 |
0.7
± 0.3 |
<0.001 |
| 5 |
Cough |
20.1
± 1.2 |
4.6
± 0.6 |
<0.001 |
| 6 |
Insomnia |
33.3
± 1.4 |
3.3
± 0.5 |
<0.001 |
| 7 |
Irritation |
37.5
± 1.5 |
6.6
± 0.8 |
<0.001 |
| 8 |
Fatigue |
72.7
± 1.4 |
17.2
± 1.1 |
<0.001 |
| 9 |
Impaired
work capacity |
58.0
± 1.5 |
5.7
± 0.7 |
<0.001 |
| 10 |
Unpleasant
sensations |
70.8
± 1.4 |
7.8
± 0.8 |
<0.001 |
| 11 |
Joint
aches |
37.0
± 1.5 |
15.4
± 1.1 |
<0.001 |
| 12 |
Depressed
mood |
37.6
± 1.5 |
9.3
± 0.9 |
<0.001 |
Alteration in the respiratory system and
oxygen supply and mental working capacity in children
with cerebral palsy.
Research Study conducted by AZ Kolchinskaya et al. "Rainbow"
Children's Rehabilitation Centre Nalchik, Russian Federation.
IHT group (n=78) and control group(n=50).
Before IHT
After IHT
Parameters of
external respiration
Parameters of external respiration
TABLE 4.
Reduction in mortality from coronary
heart disease in men residing at high altitude. The
New England Journal of Medicine 1977
Study looking at the mortality from coronary
heart disease in over 6 million subjects in 5 sets of
countries, grouped at altitude in 305 m increments.
The study showed a decline in mortality from the lowest
to the highest altitude for males but not females. Read
the abstract (PDF)
Effects of IHT on blood lipid concentrations
in male coronary heart disease patients. 2002
Total Cholesterol decreased by 7% on completion of
a course of IHT. Improving to 9% after 3 months. Remained
at that level at 6 months.
The ratio of HDL (High Density Lipoprotein) and LDL
(Low Density Lipoprotein) improved. HDL increased to
12% at 3 months and remained high at month 6. LDL levels
declined but were most apparent at month 3 (13%) and
month 6 (11%)
CA (Coefficient of artherogenity) declined
by 26% after IHT and 37% by month 3. CA is thought to
be an integral measure of plasma atherogenic potential.
Read
the abstract (PDF)
Anthihypertensive efficacy of
adaption to Intermittent Hypoxia Vs Beta-Blocker and
NO donor therapy: Role of nitric Oxide.
Institute of General Pathology and Pathophysiology,
Moscow, Russia
The study objective was to compare drug and non-drug
stimulation of nitric oxide synthesis. The study was
conducted on Rats for 40 days. Group 1 were subjected
to IHT. Group 2 took a nitric oxide donor every 4th
day, Dinitrosyl Iron complex (DINC 170 ug/kg). Group
3 took the Beta-Blocker Nebrivlol (1.25mg/kg). The IHT
and Beta-Blocker group showed a decrease in blood pressure.
The IHT group appeared to be more efficient antihypertensive
and vasoprotective means than the other two methods.
The advantages of IHT can be due to the following mechanisms:
IHT both stimulates nitric oxide synthesis and induces
expression of the gene that controls nitric oxide production.
IHT results in the formation of nitric oxide stores
in the vascular wall, which may serve as an additional
source of free nitric oxide.
IHT activates antioxidant enzymes and thereby prevents
detrimental effects of free radicals on nitric oxide
synthesis.
IHT possesses additional antihypertensive mechanisms
such as stimulation of sodium and water secretion, decreasing
vascular adrenoreactivity, etc.
Read
the abstract (PDF)
|
